CTOR vs PH
Citius Oncology, Inc. (CTOR) versus Parker-Hannifin Corporation (PH) — a side-by-side from cached financials, not a winner call.
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
CTOR does not have a complete income-statement cache yet.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
CTOR currently screens at market cap $105.2M. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Not investment advice. Open the CTOR and PH stock pages for the full models.
Not investment advice.